| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.2M | +19.3% |
| SG&A Expense | $5.4M | -1.7% |
| Operating Income | -$10.7M | -7.6% |
| Income Tax | $0 | — |
| Net Income | -$10.5M | -6.0% |
| EPS (Basic) | -$6.83 | -2176.7% |
| EPS (Diluted) | -$6.83 | -2176.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | -14.1% |
| Current Assets | $17.6M | -8.1% |
| Total Assets | $18.8M | -13.5% |
| Current Liabilities | $2.5M | -5.5% |
| Total Liabilities | $3.1M | -15.8% |
| Stockholders' Equity | $15.7M | -13.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -18.4% |
| Capital Expenditures | $160K | +107.8% |
| Investing Cash Flow | -$160K | -107.8% |
| Financing Cash Flow | $8.0M | -6.4% |
| Free Cash Flow | -$10.6M | -19.2% |